Join the Breast Cancer, Metastatic group to help and get support from people like you.
Breast Cancer, Metastatic News (Page 2)
Related terms: Metastatic Breast Cancer
Many Women Undergo Annual Mammography, Despite Biennial Screening Recommendations
FRIDAY, March 28, 2025 – A high proportion of women seem to undergo mammography screening every year, despite recommendations for biennial screening, according to a research letter published online...
Reported Breast, Colorectal Cancer Screening Higher in 2023 Than 2019
MONDAY, March 17, 2025 – In 2023, reported breast and colorectal cancer screening rebounded from pandemic-related declines, and rates were higher than in 2019, according to a research letter...
Female Breast Cancer Mortality Has Stopped Declining in Certain Age Groups
WEDNESDAY, March 12, 2025 – Breast cancer mortality rates have stopped declining in U.S. women aged 20 to 39 years and in those aged 75 years and older, according to a study published online March 6...
Breast Cancer Incidence Rates Vary by Region in U.S. Women Younger Than 40
THURSDAY, Feb. 27, 2025 – For U.S. women younger than 40 years, breast cancer incidence rates vary by geography, according to a study published online Feb. 12 in Cancer Causes & Control. Rebecca D....
Young Women's Locale Plays Role In Breast Cancer Risk
WEDNESDAY, Feb. 26, 2025 – Where a young American woman lives could play a role in her risk for breast cancer, a new study suggests. In fact, the breast cancer risk associated with a young woman’s l...
Nivolumab Added to Chemo Improves Response in ER+, HER2− Breast Cancer
THURSDAY, Feb. 6, 2025 – For patients with high-risk, early-stage estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative primary breast cancer (BC), adding...
FDA Approval Expands Earlier Use of Enhertu for Metastatic Breast Cancer
MONDAY, Feb. 3, 2025 – The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with unresectable or metastatic hormone receptor ...
Adjuvant Trastuzumab Emtansine Improves Overall Survival in HER2+ Breast Cancer
THURSDAY, Jan. 16, 2025 – For patients with human epidermal growth factor receptor 2 (HER2)-positive early breast cancer, adjuvant trastuzumab emtansine (T-DM1) improves overall survival more than...
AI-Supported Double Mammogram Reading Improves Detection Rate
TUESDAY, Jan. 14, 2025 – Artificial intelligence (AI)-supported double-reading mammography is associated with a higher breast cancer detection rate, without affecting the recall rate, compared with...
Nonadherence to Cancer Screening Varies by Screening Type
THURSDAY, Jan. 9, 2025 – Nonadherence to cancer screening varies by screening type and sex, according to a study published online Jan. 3 in JAMA Network Open. Ami E. Sedani, Ph.D., M.P.H., from the...
Individuals With Advanced Breast Cancer at Diagnosis More Likely to Have CVD
MONDAY, Jan. 6, 2025 – Individuals with advanced breast cancer at diagnosis are more likely to have prevalent cardiovascular disease (CVD), according to a study published online Jan. 2 in JAMA...
The Heart Disease, Breast Cancer Link
MONDAY, Jan. 6, 2025 – Heart disease and cancer might seem completely unrelated, but these two top causes of death sometimes act in concert. Women with heart disease appear to have a greater risk of...
Disparities Seen in Biennial Mammography Screening for Women in in Their 40s
MONDAY, Dec. 23, 2024 – For women aged 40 to 49 years, there are considerable disparities and gaps in biennial mammography screening, according to a research letter published online Dec. 20 in JAMA...
Cannabidiol Safe, May Lower Anxiety in Advanced Breast Cancer
FRIDAY, Dec. 20, 2024 – For patients with advanced breast cancer and baseline clinical anxiety, cannabidiol (CBD) is safe and may reduce anxiety levels two to four hours after ingestion, according...
San Antonio Breast Cancer Symposium, Dec. 10 to 13
The annual San Antonio Breast Cancer Symposium was held from Dec. 10 to 13 in San Antonio. Attendees included medical oncologists, radiation oncologists, researchers, and other health care p...
Further information
Related condition support groups
Related drug support groups
anastrozole, letrozole, Herceptin, Arimidex, Femara, trastuzumab, tamoxifen, Ibrance